Animal tissue devices: EU states seek permanent solution
This article was originally published in Clinica
Executive Summary
EU member states have called on the European Commission to set a deadline to the temporary solution that has been reached to ensure that medical devices utilising animal tissues may remain on the market despite not being fully in compliance with the new Directive on animal tissues (Directive 2003/32/EC), which took full effect on October 1.
You may also be interested in...
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.
Helping Organizations Deliver On KPIs And Giving Staff A Voice
ImproveWell has won awards for its software technology that allows health care staff at the sharp end of patient care to report on problems as they happen. The outcome is a real-time learning process that contributes to improved operational efficiencies for health systems, says In Vivo Rising Leader Lara Mott.
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.